Dr. J.R.K's Siddha
Ayurvedic medicines manufacturer Dindayal Industries Limited (DIL) has set itself an ambitious target of taking the turnover to Rs 125 crore by 2016.
Read More Dr. J.R.K's Siddha
“In 2013-14, the company is expecting a turnover of Rs 50 crore from the present 25 crore and in 2016 we are eyeing a turnover of Rs 125 crore,” Chairman of the Gwalior-based DIL, Anand Mohan Chhaparwal, told reporters here today after launching Chyawanprash Premium and Swarnaprash products.
The Ayurveda products market in India stands at Rs 10,000 crore at present out of which the share of Madhya Pradesh is Rs 400 crore, he said.
https://indiameds.in/Dindayal_Aushadhi_ayurvedic_online_medicine
The company which has over 500 products in its portfolio has set itself target of capturing five per cent market share in Madhya Pradesh, he added.
Ayurvedic medicines manufacturer Dindayal Industries Limited (DIL) has set itself an ambitious target of taking the turnover to Rs 125 crore by 2016.
Read More Dr. J.R.K's Siddha
“In 2013-14, the company is expecting a turnover of Rs 50 crore from the present 25 crore and in 2016 we are eyeing a turnover of Rs 125 crore,” Chairman of the Gwalior-based DIL, Anand Mohan Chhaparwal, told reporters here today after launching Chyawanprash Premium and Swarnaprash products.
The Ayurveda products market in India stands at Rs 10,000 crore at present out of which the share of Madhya Pradesh is Rs 400 crore, he said.
https://indiameds.in/Dindayal_Aushadhi_ayurvedic_online_medicine
The company which has over 500 products in its portfolio has set itself target of capturing five per cent market share in Madhya Pradesh, he added.
No comments:
Post a Comment